These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7237468)

  • 41. Increase of serum iron concentrations in rhesus monkeys and humans on administration of vincristine, vinblastine, or vindesine.
    Sethi VS; Shihabi Z; Spurr CL
    Cancer Treat Rep; 1984 Jun; 68(6):933-6. PubMed ID: 6733711
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
    Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioimmunoassays for the Vinca alkaloids, vinblastine and vincristine.
    Langone JJ; D'Onofrio MR; Van Vunakis H
    Anal Biochem; 1979 May; 95(1):214-21. PubMed ID: 495957
    [No Abstract]   [Full Text] [Related]  

  • 44. Animal models for the comparative assessment of neurotoxicity following repeated administration of vinca alkaloids.
    Todd GC; Griffing WJ; Gibson WR; Morton DM
    Cancer Treat Rep; 1979 Jan; 63(1):35-41. PubMed ID: 105807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of water stress and nitrogen nutrition on regulation of Catharanthus roseus alkaloids metabolism].
    Zhang N; Wen Q; Feng H; Cao R; Zhou X; Tagn J; Wu N
    Zhongguo Zhong Yao Za Zhi; 2012 May; 37(10):1346-52. PubMed ID: 22860440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
    McGown AT; Poppitt DG; Swindell R; Fox BW
    Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fluorescence assay and pharmacokinetics of vincamine in rats (author's transl)].
    Iven H; Siegers CP
    Arzneimittelforschung; 1977; 27(6a):1248-54. PubMed ID: 578449
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer.
    Nelson RL; Dyke RW; Root MA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():17-24. PubMed ID: 7438117
    [No Abstract]   [Full Text] [Related]  

  • 49. The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags.
    Gilbar PJ; Carrington CV
    J Oncol Pharm Pract; 2006 Jun; 12(2):113-8. PubMed ID: 16984750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differences between vinblastine and vincristine in distribution in the blood of rats and binding by platelets and malignant cells.
    Gout PW; Wijcik LL; Beer CT
    Eur J Cancer (1965); 1978 Nov; 14(11):1167-78. PubMed ID: 738324
    [No Abstract]   [Full Text] [Related]  

  • 51. UPLC-ESI-QTOF-MS assisted targeted metabolomics to study the enrichment of vinca alkaloids and related metabolites in Catharanthus roseus plants grown under controlled LED environment.
    Nagy K; Darkó É; Szalai G; Janda T; Jókai Z; Ladányi M; Rady MR; Dernovics M
    J Pharm Biomed Anal; 2023 Oct; 235():115611. PubMed ID: 37542828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental in vivo cross-resistance of vinca alkaloid drugs.
    Maral R; Bourut C; Chenu E; Mathe G
    Cancer Chemother Pharmacol; 1981; 5(3):197-9. PubMed ID: 7296754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
    Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
    Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
    Barnett CJ; Cullinan GJ; Gerzon K; Hoying RC; Jones WE; Newlon WM; Poore GA; Robison RL; Sweeney MJ; Todd GC; Dyke RW; Nelson RL
    J Med Chem; 1978 Jan; 21(1):88-96. PubMed ID: 412968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 58. Multi-compartmental modeling and kinetic parameter identification of the systemic distribution of vincamine after oral administration in the rat and in the man.
    Rognoni F; Viganó V; Periti P; Pirola LC
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):373-80. PubMed ID: 892955
    [No Abstract]   [Full Text] [Related]  

  • 59. Vinca alkaloids.
    Chabner BA; Horwitz SB; Clendennin NJ; Purvis JD
    Cancer Chemother Biol Response Modif; 1991; 12():67-73. PubMed ID: 1681845
    [No Abstract]   [Full Text] [Related]  

  • 60. Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention.
    Zhigaltsev IV; Maurer N; Akhong QF; Leone R; Leng E; Wang J; Semple SC; Cullis PR
    J Control Release; 2005 May; 104(1):103-11. PubMed ID: 15866338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.